25 Sep 26 PLI Scheme Boosts India’s Bulk Drug Manufacturing for Self-Reliance
PLI scheme underpins India’s bulk drug production—key APIs like Penicillin G & Clavulanic Acid now made domestically, cutting imports, enhancing drug supply c...
PLI scheme underpins India’s bulk drug production—key APIs like Penicillin G & Clavulanic Acid now made domestically, cutting imports, enhancing drug supply c...
Press Information Bureau reports PLI schemes strengthened India's pharma, API, and medical device sectors by reducing import dependence and boosting domestic ...
Know how India's PLI scheme for pharma sector has disbursed ₹6,659 crore by March 2026, challenges in bulk drugs, and future prospects for UPSC & State PCS ex...
UPSC aspirants must know: PLI scheme for pharma sector launched in 2022-23. ₹6,659 crore disbursed by March 2026. Challenges in bulk drug production & delays ...
Government approves 48 PLI projects for bulk drugs with ₹6,940 crore outlay. 18 APIs like Penicillin G, Dexamethasone now produced domestically, reducing impo...
Know about India's Production Linked Incentive (PLI) Scheme for Pharmaceuticals: ₹15,000 Cr outlay, ₹6,659 Cr disbursed by March 2026, challenges in bulk drug...
Government approves 48 PLI projects under Bulk Drugs Scheme with ₹6,940 crore outlay to boost domestic API production, reducing import dependency for 18 key d...
Government’s PLI scheme for pharma sector allocates ₹15,000 crore; ₹6,659 crore disbursed by March 2026. Challenges in bulk drug projects explained for UPSC &...
UPSC Exam: Govt releases PLI scheme progress for pharma sector. ₹6,659 crore disbursed under drugs PLI, ₹87.70 crore under bulk drugs PLI by March 2026. Key c...
48 PLI projects worth ₹6,940 crore approved for bulk drugs to reduce API imports. 18 APIs now in production. UPSC & State PCS key for governance and self-reli...